101. Adipokines as New Biomarkers of Immune Recovery: Apelin Receptor, RBP4 and ZAG Are Related to CD4+ T-Cell Reconstitution in PLHIV on Suppressive Antiretroviral Therapy
- Author
-
Instituto de Salud Carlos III, European Commission, Agència de Gestió d'Ajuts Universitaris i de Recerca, Red Española de Investigación en SIDA, Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (España), Institut d'Investigació Sanitària Pere Virgili, Yeregui, Elena, Masip, Jenifer, Viladés, Consuelo, Domingo, Pere, Pacheco, Yolanda M., Blanco, Julià, Mallolas, Josep, Alba, Verónica, Vargas, Montserrat, García-Pardo, Graciano, Negredo, Eugenia, Olona, Montserrat, Vidal-González, Judit, Peraire, Maria, Martí, Anna, Reverté, Laia, Gómez-Bertomeu, Frederic, Leal, Manuel, Vidal, Francesc, Peraire, Joaquim, Rull, Anna, Instituto de Salud Carlos III, European Commission, Agència de Gestió d'Ajuts Universitaris i de Recerca, Red Española de Investigación en SIDA, Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (España), Institut d'Investigació Sanitària Pere Virgili, Yeregui, Elena, Masip, Jenifer, Viladés, Consuelo, Domingo, Pere, Pacheco, Yolanda M., Blanco, Julià, Mallolas, Josep, Alba, Verónica, Vargas, Montserrat, García-Pardo, Graciano, Negredo, Eugenia, Olona, Montserrat, Vidal-González, Judit, Peraire, Maria, Martí, Anna, Reverté, Laia, Gómez-Bertomeu, Frederic, Leal, Manuel, Vidal, Francesc, Peraire, Joaquim, and Rull, Anna
- Abstract
A significant proportion of people living with HIV (PLHIV) who successfully achieve virological suppression fail to recover CD4+ T-cell counts. Since adipose tissue has been discovered as a key immune organ, this study aimed to assess the role of adipokines in the HIV immunodiscordant response. This is a multicenter prospective study including 221 PLHIV starting the first antiretroviral therapy (ART) and classified according to baseline CD4+ T-cell counts/µL (controls > 200 cells/µL and cases ≤ 200 cells/µL). Immune failure recovery was considered when cases did not reach more than 250 CD4+ T cells/µL at 144 weeks (immunological nonresponders, INR). Circulating adipokine concentrations were longitudinally measured using enzyme-linked immunosorbent assays. At baseline, apelin receptor (APLNR) and zinc-alpha-2-glycoprotein (ZAG) concentrations were significantly lower in INRs than in immunological responders (p = 0.043 and p = 0.034), and they remained lower during all ART follow-up visits (p = 0.044 and p = 0.028 for APLNR, p = 0.038 and p = 0.010 for ZAG, at 48 and 144 weeks, respectively). ZAG levels positively correlated with retinol-binding protein 4 (RBP4) levels (p < 0.01), and low circulating RBP4 concentrations were related to a low CD4+ T-cell gain (p = 0.018 and p = 0.039 at 48 and 144 weeks, respectively). Multiple regression adjusted for clinical variables and adipokine concentrations confirmed both low APLNR and RBP4 as independent predictors for CD4+ T cells at 144 weeks (p < 0.001). In conclusion, low APLNR and RBP4 concentrations were associated with poor immune recovery in treated PLHIV and could be considered predictive biomarkers of a discordant immunological response.
- Published
- 2022